GENE ONLINE|News &
Opinion
Blog

China
Weekly in Asia | SEP
2019-09-11
Weekly Top 5 in China (0310-0316)
2019-03-19
Weekly Top 5 in China (0224-0302)
2019-03-11
Weekly Top 5 in China (0210-0216)
2019-02-18
The Scientists Strongly Condemned for the First Gene Editing Baby’s Birth in China
2018-11-27
Fruquintinib becomes the first homegrown oncology drug approved in China for major indication
2018-09-11
US FDA Allows Phase II Clinical Trials for China’s anti-HIV Two-Drug Combo Therapy
2018-09-07
China’s Tasly, TCM Pharma, Plans to List in $1 Billion Hong Kong IPO
2018-03-06
1 6 7 8
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top